Why Is Cogent Biosciences Stock Trading Higher On Monday?

benzinga.com/news/health-care/25/07/46273670/why-is-cogent-biosciences-stock-trading-higher-on-monday-2

Cogent Biosciences, Inc.‘s (NASDAQ:COGT) bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder.
With statistically significant improvements across all endpoints—including symptom reduction and…

This story appeared on benzinga.com, 2025-07-07 13:22:49.
The Entire Business World on a Single Page. Free to Use →